{
    "nctId": "NCT06503380",
    "briefTitle": "Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer",
    "officialTitle": "Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Hematological Toxicity, Targeted Therapy, Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "Incidence of cancer treatment induced neutropenia (CIN)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \u00b7 The patients signed the informed consent and voluntarily participated in the study.\n\n  * A definite diagnosis of any type of breast cancer.\n  * Receiving or has completed targeted therapies.\n  * Investigator judged that the patient need to receive or had received treatment or prevention for CTIT, CIN or CRA induced by targeted therapies.\n\nExclusion Criteria:\n\n* \u00b7 Pregnant or lactating women.\n\n  * Failure to understand the study or to obtain informed consent.\n  * The investigator determined other situations that are not suitable for inclusion.",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}